OBSV Stock Price - ObsEva S.A. Stock Quote (U.S.: Nasdaq) - MarketWatch

Open $14.50
Day Range 14.20 - 14.80
52 Week Range 6.77 - 20.35
Market Cap $619.98M
Shares Outstanding 42.79M
Public Float 16.8M
Beta 0.19
Rev. per Employee n/a
P/E Ratio n/a
EPS $-2.10
Yield n/a
Dividend n/a
Ex-Dividend Date n/a
Short Interest 36.87K 08/31/18
% of Float Shorted 0.22%
Average Volume 133.18K

5 Day	8.72%
1 Month	15.02%
3 Month	-4.00%
YTD	47.54%
1 Year	106.30%

MarketWatch
Other Dow Jones

ObsEva started at overweight with $29 stock price target at J.P. Morgan

Sep. 13, 2018 at 7:13 a.m. ET
by Tomi Kilgore

AbbVie, Neurocrine shares rise after positive results for uterine fibroids drug

Feb. 21, 2018 at 8:34 a.m. ET
by Emma Court

This drug may be able to treat both women’s health disorders and prostate cancer

Oct. 16, 2017 at 7:39 a.m. ET
by Emma Court

No Headlines Available

Other News
Press Releases

Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV) and Immune Design (IMDZ)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just ...[...]

Aug. 29, 2018 at 7:10 a.m. ET
on SmarterAnalyst

Obseva SA (OBSV) CEO Ernest Loumaye on Q2 2018 Results - Earnings Call Transcript

Aug. 11, 2018 at 10:42 a.m. ET
on Seeking Alpha

ObsEva SA (OBSV) Reports Q2 Loss, Misses Revenue Estimates

ObsEva SA (OBSV) delivered earnings and revenue surprises of 9.26% and -100.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

Aug. 8, 2018 at 7:30 a.m. ET
on Zacks.com

Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV), AstraZeneca (AZN) and Bluebird Bio (BLUE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just ...[...]

Aug. 6, 2018 at 6:59 p.m. ET
on SmarterAnalyst

ObsEva SA (OBSV) Sees Hammer Chart Pattern: Time to Buy?

ObsEva has been struggling lately, but the selling pressure may be coming to an end soon.

Aug. 2, 2018 at 5:53 a.m. ET
on Zacks.com

Premarket analyst action - healthcare

Jul. 19, 2018 at 7:32 a.m. ET
on Seeking Alpha

ObsEva SA Received its Third Buy in a Row

After BMO Capital and RBC Capital gave ObsEva SA (NASDAQ: OBSV) a Buy rating last ...[...]

Jul. 16, 2018 at 7:16 a.m. ET
on SmarterAnalyst

Premarket Gainers as of 9:05 am (07/13/2018)

Jul. 13, 2018 at 9:11 a.m. ET
on Seeking Alpha

ObsEva SA to start trading today on the SIX Swiss Exchange

Jul. 13, 2018 at 7:37 a.m. ET
on Seeking Alpha

Your Daily Pharma Scoop: TG Therapeutics Phase 2 Results, Geron Positive, Agio In Phase 3

Jun. 20, 2018 at 8:00 a.m. ET
on Seeking Alpha

ObsEva announces pricing of follow-on offering

Jun. 20, 2018 at 7:37 a.m. ET
on Seeking Alpha

ObsEva up 34% premarket on successful mid-stage linzagolix study

Jun. 18, 2018 at 9:20 a.m. ET
on Seeking Alpha

Premarket analyst action - healthcare

Jun. 12, 2018 at 8:49 a.m. ET
on Seeking Alpha

ObsEva SA Ordinary Shares (OBSV) Q1 2018 Earnings Conference Call Transcript

May. 17, 2018 at 7:16 p.m. ET
on Motley Fool

ObsEva' (OBSV) CEO Ernest Loumaye Q1 2018 Results - Earnings Call Transcript

May. 16, 2018 at 1:04 p.m. ET
on Seeking Alpha

Key events next week - healthcare

Apr. 20, 2018 at 7:43 a.m. ET
on Seeking Alpha

ObsEva (OBSV) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

Apr. 11, 2018 at 1:19 p.m. ET
on Seeking Alpha

Key events next week - healthcare

Mar. 2, 2018 at 11:03 a.m. ET
on Seeking Alpha

Your Daily Pharma Scoop: Progenics Update, La Jolla Data, ARCA Biopharma Setback

Feb. 27, 2018 at 8:00 a.m. ET
on Seeking Alpha

Biotech Forum Daily Digest For February 26th

Feb. 26, 2018 at 11:17 a.m. ET
on Seeking Alpha

ObsEva SA to Participate in September Investor Conferences

Aug. 28, 2018 at 1:30 a.m. ET
on GlobeNewswire

ObsEva SA to Participate in September Investor Conferences

Aug. 28, 2018 at 1:30 a.m. ET
on Globe Newswire

New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Constellium N.V, Just Energy Group, Hovnanian Enterprises, and First Majestic Silver -- Factors of Influence, Major Initiatives and Sustained Production

New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Constellium N.V, Just Energy Group, Hovnanian Enterprises, and First Majestic Silver -- Factors of Influence, Major Initiatives and Sustained Production

Aug. 21, 2018 at 8:25 a.m. ET
on GlobeNewswire

ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

Aug. 10, 2018 at 1:31 a.m. ET
on GlobeNewswire

ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

Aug. 10, 2018 at 1:30 a.m. ET
on Globe Newswire

ObsEva SA to Host Earnings Call

Aug. 8, 2018 at 6:02 a.m. ET
on ACCESSWIRE

ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug. 8, 2018 at 1:00 a.m. ET
on Globe Newswire

ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

Jul. 31, 2018 at 1:31 a.m. ET
on GlobeNewswire

ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

Jul. 31, 2018 at 1:30 a.m. ET
on Globe Newswire

ObsEva Expands Executive Team Hiring a Chief Commercial Officer

Jul. 25, 2018 at 1:31 a.m. ET
on GlobeNewswire

ObsEva Expands Executive Team Hiring a Chief Commercial Officer

Jul. 25, 2018 at 1:30 a.m. ET
on Globe Newswire

ObsEva SA to start trading today on the SIX Swiss Exchange

Jul. 13, 2018 at 1:31 a.m. ET
on GlobeNewswire

ObsEva SA to start trading today on the SIX Swiss Exchange

Jul. 13, 2018 at 1:30 a.m. ET
on Globe Newswire

Global Endometriosis Market 2018 Share, Trend, Segmentation and Forecast to 2023

Jul. 10, 2018 at 5:27 a.m. ET
on Heraldkeeper

ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

Jul. 6, 2018 at 1:31 a.m. ET
on GlobeNewswire

ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

Jul. 6, 2018 at 1:30 a.m. ET
on Globe Newswire

ObsEva Announces Pricing of Follow-on Public Offering

Jun. 20, 2018 at 2:49 a.m. ET
on GlobeNewswire

ObsEva Announces Pricing of Follow-on Public Offering

Jun. 20, 2018 at 2:49 a.m. ET
on Globe Newswire

ObsEva Announces Launch of Proposed Follow-on Public Offering

Jun. 18, 2018 at 4:32 p.m. ET
on GlobeNewswire

ObsEva Announces Launch of Proposed Follow-on Public Offering

Jun. 18, 2018 at 4:31 p.m. ET
on Globe Newswire

ObsEva SA engages in the development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland. (See Full Profile)